Doctor profile · Federal record
Dr. Vijayabhanu Mahadevan, M.D.
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Surprise, AZ
- NPI 1083727333
- Accepts Medicare
- MIPS 85.4 / 100 · 2023
- 32 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12665 W Smokey Dr # 140, #140
Surprise, AZ 853783703
(623) 219-4040
fax (623) 219-4050
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- February 13, 2023
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (2)
- Arizona #37475 · Virginia #0101230340
- Medicaid
- AZ #260994
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083727333. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
237,390
Distinct HCPCS
10
Medicare allowed
$3,295,293
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 93,600 | 25 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 68,560 | 14 | $6 | |
J0897 |
Injection, denosumab, 1 mg | 25,680 | 266 | $23 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 19,925 | 34 | $42 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 18,060 | 15 | $10 | |
J9312 |
Injection, rituximab, 10 mg | 3,250 | 16 | $80 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,050 | 13 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,254 | 632 | $123 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,068 | 300 | $70 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 802 | 571 | $87 |
In context: peer comparison
Among 2 peers in Surprise Rheumatology Physician, average services per provider: 8,044. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$281
Transactions
13
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 4 | $69.10 | |
| Radius Health, INC. | 2 | $47.10 | |
| Abbvie INC. | 1 | $30.53 | |
| Pfizer INC. | 1 | $29.17 | |
| Genzyme Corporation | 1 | $23.41 | |
| Janssen Biotech, INC. | 1 | $23.05 | |
| GlaxoSmithKline, LLC. | 1 | $22.68 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $19.61 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.85 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,230
Patients
1,360
Total drug cost
$125,252
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 1,029 | 327 | $9,995 |
| Hydroxychloroquine Sulfate | Generic | 945 | 280 | $54,267 |
| Methotrexate (Methotrexate Sodium) | Brand | 689 | 217 | $23,424 |
| Leflunomide | Generic | 242 | 72 | $17,280 |
| Tramadol Hcl | Generic | 154 | 50 | $718 |
| Alendronate Sodium | Generic | 149 | 53 | $1,661 |
| Duloxetine Hcl | Generic | 148 | 55 | $3,033 |
| Sulfasalazine | Generic | 135 | 47 | $3,166 |
| Folic Acid | Generic | 131 | 41 | $556 |
| Celecoxib | Generic | 122 | 43 | $1,656 |
Frequently asked questions
What is Dr. Vijayabhanu Mahadevan's medical specialty?
Dr. Vijayabhanu Mahadevan practices Rheumatology Physician in Surprise, AZ.
Where does Dr. Vijayabhanu Mahadevan practice?
Dr. Vijayabhanu Mahadevan practices at 12665 W Smokey Dr # 140, Surprise, AZ 853783703. Office phone: 6232194040.
What is Dr. Vijayabhanu Mahadevan's NPI?
Dr. Vijayabhanu Mahadevan's National Provider Identifier (NPI) is 1083727333, issued by NPPES.
Does Dr. Vijayabhanu Mahadevan accept Medicare assignment?
Yes. Dr. Vijayabhanu Mahadevan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vijayabhanu Mahadevan commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.